Good Samaritan Hospital, Cincinnati   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Cincinnati OH United States (1852)

Organization Overview

First Clinical Trial
2007
NCT00492102
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

CCHMC | CCHMC/Good Samaritan

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 2)

Birth Weight (Phase 1)

Bronchopulmonary Dysplasia (Phase 1)

Choanal Atresia (Phase 4)

Cystic Fibrosis (Phase 4)

Fanconi Anemia (Phase 2)

Fanconi Syndrome (Phase 2)

Fibrosis (Phase 4)

Leukemia, Myeloid, Acute (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 12